ISRG

Rating buyAI Memo

Intuitive Surgical

As of 2026-01-24/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-01-24 • Model: RankAlpha Sentiment AI

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

buy

Confidence

medium

Horizon

—

Key catalyst

Regulatory/clearance or material product milestone • 2026-07-23

Expected move: +45%

Biggest risk

Slower procedure growth, regulatory delays, or intensifying competition reduce install cadence and compress recurring revenue, moving shares toward the analyst low.

Invalidation

Break below $440 or thesis failure.

What would change my mind?

Sustained multi-specialty adoption, faster replacement cycles, and successful product upgrades drive outsized consumable/service revenue growth and multiple expansion toward the analyst high.

Research note

Recommendation

buy

Confidence

medium

As of

2026-01-24

Base target

$616

p=60%

Bull target

$750

p=20%

Bear target

$440

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Q1 2026 quarterly earnings release
Global install-base expansion and procedure adoption
Sustained multi-specialty adoption, faster replacement cycles, and successful product upgrades drive outsized consumable/service revenue growth and multiple expansion toward the analyst high.

BearKey bullets

Intensifying competition for robotics and hospital capital
Regulatory delays or failed clearances for new devices
Reimbursement cuts or constrained hospital budgets

WatchKey bullets

Regulatory/clearance or material product milestone

Summary

High-level snapshot

Recommendation

buy

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $616 (p=60%)

Bull/Bear spread: +77% / +4%

Vs latest close: Bull +77% · Base +45% · Bear +4%

Scenario probabilities

Bull Target: $750 (p=20%)Base Target: $616 (p=60%)Bear Target: $440 (p=20%)

Commentary

Consensus is constructive with a median near $616, but the wide high/low range signals execution sensitivity and differing views on adoption pace [#SERP-4]. Market reaction to the latest quarter was mixed—strong revenue/EPS but cautious FY26 guidance—prompting near-term profit-taking [#SERP-2]. Longer-term sentiment emphasizes structural upside from expanding procedure mix and recurring consumables as the primary value driver [#SERP-3].

As of 2026-01-24 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Sustained multi-specialty adoption, faster replacement cycles, and successful product upgrades drive outsized consumable/service revenue growth and multiple expansion toward the analyst high.

Bear Case

Slower procedure growth, regulatory delays, or intensifying competition reduce install cadence and compress recurring revenue, moving shares toward the analyst low.

Drivers

Scannable catalysts and supporting factors

Q1 2026 quarterly earnings release
Global install-base expansion and procedure adoption

Human Analyst Targets

External snippets for comparison only; verify at source.

Unverified externalLast fetched 2026-01-24Source quality: external scrape

External snippets are unverified; treat as directional signals only. Always confirm with the original provider.

Inline RA est

Provider

serper

Median (USD)

$616.48

Range (USD)

$440.00 - $750.00

Count

Query: Intuitive Surgical Inc Common (ISRG) analyst consensus price target high low average

Intuitive Surgical (ISRG) Stock Forecast & Price Target - MarketBeat
Search result #1
The highest price target for ISRG is $750.00, while the lowest price target for ISRG is $440.00. The average price target represents a forecasted upside of ...
Extracted: $750.00, $440.00Open source
Intuitive Surgical, Inc. (ISRG) - Yahoo Finance
Search result #2
Intuitive Surgical (ISRG) reported strong Q4 results with $2.87 billion in revenue and $2.53 in adjusted earnings per share (EPS), but issued cautious guidance ...
Extracted: $2.87, $2.53Open source
Intuitive Surgical, Inc.: Target Price Consensus and Analysts ...
Search result #3
Mean consensus. OUTPERFORM ; Number of Analysts. 35 ; Last Close Price. 523.99USD ; Average target price. 608.25USD ; Spread / Average Target. +16.08%.
Extracted: $523.99, $608.25Open source
Intuitive Surgical Inc. Analyst Estimates - ISRG - MarketWatch
Search result #4
Stock Price Targets. High, $740.00. Median, $622.00. Low, $440.00. Average, $616.48. Current Price, $525.81. Yearly Numbers. Estimates. ISRG will report 2026 ...
Extracted: $740.00, $622.00, $440.00, $616.48, $525.81Open source
Intuitive Surgical, Inc. (ISRG) Price Targets
Search result #5
The forecasts for Intuitive Surgical, Inc. (ISRG) range from a low of $440 to a high of $740. The average price target represents a increase of $18.69 from the ...
Extracted: $440.00, $740.00, $18.69Open source
ISRG | Intuitive Surgical Inc. Analyst Estimates & Ratings – WSJ
Search result #6
Stock Price Target ISRG. High, $740.00. Median, $616.00. Low, $440.00. Average, $616.78. Current Price, $525.81. Related Links: Options · Overview · Research & ...
Extracted: $740.00, $616.00, $440.00, $616.78, $525.81Open source

Scenarios

Bull Target (Scenario probability)

$750 / p=20% prob

Base Target (Scenario probability)

$616 / p=60% prob

Bear Target (Scenario probability)

$440 / p=20% prob

Price $425 as of 2026-05-29

Nearest Scenario: Bear (∆ 4%)

Targets vs latest close: Bull +77% · Base +45% · Bear +4%

Sentiment & Exposure

Sentiment unavailable: insufficient coverage

Events

Other notable items detected

EVENT2026-07-23
Regulatory/clearance or material product milestone
Any major FDA clearance or announced upgrade to the da Vinci platform could be a discrete re-rating event for adoption and service revenue; assumed conservative mid-year window for planning purposes [#SERP-1].
Prob 30.00% • Move 12.00% • Priced-in 30.00%

Short-term Catalysts

Next few weeks

Q1 2026 quarterly earnings release
2026-04-24
Quarterly results and forward guidance that can reprice expectations for procedure volumes and recurring revenue; prior commentary showed strong revenue/EPS but cautious guidance [#SERP-2].
Prob 65% • Move 6% • Priced-in 40%

Long-term Catalysts

Months to a year

Global install-base expansion and procedure adoption
2027-01-24
Sustained adoption in new specialties and international markets expanding recurring consumable/service revenue over the next year; payoff expected over a ~12-month horizon [#SERP-3].
Prob 55% • Move 25% • Priced-in 60%

Risks

Intensifying competition for robotics and hospital capital
Regulatory delays or failed clearances for new devices
Reimbursement cuts or constrained hospital budgets
Slower-than-expected procedure adoption or downward guidance

Peers

Symbol	Summary
SYK	Stryker: major surgical- and OR-systems OEM with expanding minimally invasive and robotic-adjacent products; competes for the same hospital capital budgets.
MDT	Medtronic: diversified medtech with surgical partnerships and broad hospital reach; useful comparator on adoption cycles and reimbursement exposure.
ZBH	Zimmer Biomet: orthopedic-focused device maker with OR solutions and comparable exposure to hospital procurement and procedure volumes.
SNN	Smith & Nephew: surgical and orthopedics specialist with arthroscopy and wound-care franchises; competes on tools and hospital relationships that influence adoption.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment AI
Human targets: serper
Targets query: Intuitive Surgical Inc Common (ISRG) analyst consensus price target high low average
Analysis date: 2026-01-24

AI Stock Memo: ISRG - Intuitive Surgical - RankAlpha